ALT-to-Lymphocyte Ratio as a Predictor of Long-Term Mortality in Patients with Normal Liver Function Presenting Coronary Artery Disease after Undergoing PCI: A Retrospective Cohort Study
Table 1
Characteristics of participants of the two groups and clinical outcomes.
Variables
ALR < 14.06
ALR ≥ 14.06
χ2 or t
n = 1804
n = 910
Age, years
63.313 ± 10.571
64.245 ± 10.737
−2.157
0.031
Gender (male), n (%)
1163 (64.5)
673 (74.0)
24.882
<0.001
Family history, n (%)
354 (19.7)
148 (16.5)
4.067
0.044
Heart rate, beats/min
74.170 ± 21.841
74.440 ± 11.617
−0.339
0.734
Smoking, n (%)
535 (29.7)
280 (30.8)
0.357
0.55
Drinking, n (%)
288 (16.0)
150 (16.5)
0.12
0.729
Hypertension, n (%)
1044 (57.9)
493 (54.2)
3.364
0.067
Diabetes mellitus, n (%)
498 (27.6)
191 (21.0)
13.979
<0.001
BUN, mmol/L
5.833 ± 4.694
5.703 ± 4.453
0.685
0.493
Cr, mmol/L
71.608 ± 34.046
75.747 ± 46.709
−2.617
0.009
UA, mmol/L
297.273 ± 83.160
303.531 ± 88.172
−1.805
0.071
TG, mmol/L
1.713 ± 1.140
1.594 ± 1.128
2.528
0.012
TC, mmol/L
3.935 ± 1.013
3.753 ± 1.035
4.286
<0.001
HDL-C, mmol/L
1.043 ± 0.304
1.030 ± 0.298
1.024
0.306
LDL-C, mmol/L
2.421 ± 0.858
2.279 ± 0.814
4.043
<0.001
All-cause mortality, n (%)
48 (2.7)
50 (5.5)
13.956
<0.001
Cardiac mortality, n (%)
30 (1.7)
29 (3.2)
6.605
0.01
MACEs, n (%)
215 (11.9)
101 (11.1)
0.394
0.53
MACCEs, n (%)
285 (15.8)
133 (14.6)
0.65
0.42
Stroke, n (%)
79 (4.4)
35 (3.8)
0.427
0.513
Bleeding, n (%)
52 (2.9)
25 (2.7)
0.04
0.841
Readmission, n (%)
564 (31.3)
252 (27.7)
3.67
0.055
Cardiac insufficiency, n (%)
289 (16.0)
121 (13.3)
3.498
0.061
Secondary MI, n (%)
57 (3.2)
22 (2.4)
1.179
0.278
BUN, blood urea nitrogen; Cr, creatinine; UA, uric acid; TG, triglyceride; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; MACEs, major adverse cardiovascular events; MACCEs, major adverse cardiovascular and cerebrovascular events; MI, myocardial infarction.
